12th ASM Conference on Candida and Candidiasis

第 12 届 ASM 念珠菌和念珠菌病会议

基本信息

批准号：
8651701
负责人：
Theodore C. White
金额：
$ 0.8万
依托单位：
AMERICAN SOCIETY FOR MICROBIOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-02-01 至 2015-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8651701
关键词：
AIDS/HIV problem Achievement Acquired Immunodeficiency Syndrome Address Affect Agreement American Antifungal Agents Area Azoles Biological Candida Candida albicans Candida glabrata Candidiasis Case Study Cell Communication Chemotherapy-Oncologic Procedure Clinical Collaborations Communicable Diseases Communities Community Developments Development Diagnosis Disease Disseminated candidiasis Drug Interactions Drug resistance Educational workshop Effectiveness Epidemiology Esophageal Failure Feedback Filler Financial Support Frequencies Funding Fungal Drug Resistance Genes Genomics Goals Growth Guidelines Healthcare Host Defense Human Imagination Immune Immune response Immunocompetent Immunocompromised Host Immunology Individual Infection International Lead Life Medical Metabolic Microbial Biofilms Microbiology Minority Modeling Molecular Morphogenesis Names Neonatal Intensive Care Units Oral Oropharyngeal Participant Partner in relationship Pathogenicity Patients Premature Infant Prophylactic treatment Proteomics Publications Recording of previous events Research Research Personnel Resources Role San Francisco Scientist Series Signal Transduction Societies Surveys System Systems Biology Techniques Technology The science of Mycology Time Training Vaccines Vagina Woman abstracting base candidemia career flexibility fungus genome annotation genome sequencing in vivo interest meetings member mutant new technology pathogen posters prevent programs public health relevance resistance mechanism response screening success symposium therapeutic vaccine tool transcriptomics

项目摘要

DESCRIPTION (provided by applicant): Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, vaccines and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 12th Conference on Candida and Candidiasis, which will be held from 26-30 March, 2014, in New Orleans, LA. The conference will be sponsored by the American Society for Microbiology, which will provide both management expertise and financial support. The program will be based upon past conferences in the series, which have reliably drawn attendance of around 400 American and International scientists, and have been met with enthusiastic support in participant surveys. This program will include 34 speakers chosen for their expertise in fundamental and/or clinical mycology and 62 speakers who will be selected based on submitted abstracts. This arrangement will provide the flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established community members as speakers. There will be clinical talks about the epidemiology, diagnosis, and treatment of candidiasis, with speakers carefully prescreened for affability and effectiveness. These talks will be incorporated into sessions that focus on various key aspects of candidal infections, including environmental signaling, antifungal agents and resistance, immune recognition, vaccines, morphogenesis, and biofilms. In a lunch session on Candida case reports, clinicians will inform basic scientists about the challenges of diagnosing and treating different types of infection. Informal parallel sessions will address infection models, metabolic adaptation, fungal drug interactions and new technologies while further encouraging productive interaction and discussion. There will be a poster session each afternoon to allow ample discussion of the 250-300 posters that will be presented. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved.

描述（由申请人提供）：念珠菌是人类的主要真菌病原体，导致疾病从口腔和阴道念珠菌病到威胁生命的念珠菌血症和入侵性疾病。念珠菌场的重点是与流行病学，耐药性，感染，宿主反应，疫苗和治疗学有关的广泛受试者。每两年举行一次念珠菌和念珠菌会议是介绍前沿进步和这些不同领域的最新观点的主要论坛。要求资金为第12届念珠菌和念珠菌病提供部分支持，该会议将于2014年3月26日至30日在洛杉矶新奥尔良举行。会议将由美国微生物学会赞助，该学会将提供管理专业知识和财务支持。该计划将基于该系列的过去会议，该系列的大约400名美国和国际科学家的出席性可靠，并在参与者的调查中得到了热情的支持。该计划将包括34名因基本和/或临床真菌学专业知识而被选为的演讲者，以及将根据提交的摘要选择的62位发言人。这种安排将提供灵活性，以展现最先进的进步，并以演讲者的身份吸引各种各样的新兴和建立的社区成员。关于念珠菌病的流行病学，诊断和治疗的临床谈判，仔细预先筛选了有关伴侣和有效性的说话者。这些谈判将纳入会议中，以关注候选感染的各个关键方面，包括环境信号，抗真菌剂和抗药性，免疫识别，疫苗，形态发生和生物膜。在关于Candida病例报告的午餐会议中，临床医生将向基础科学家告知诊断和治疗不同类型感染的挑战。非正式的平行课程将解决感染模型，代谢适应性，真菌药物相互作用和新技术，同时进一步鼓励生产性互动和讨论。每天下午都会有一个海报会议，以允许对250-300海报的充分讨论。我们相信，我们的目标 - 介绍该领域的最新进展，以聚焦初级科学家（尤其是妇女和少数群体）的成就，以促进协同和跨学科的互动，并提供社区范围内的讨论场所。